Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind, placebo-controlled trial evaluating a gastroesophageal reflux disease therapy in patients with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Emory University | Conditions: Asthma | Phase 4 | Status: UNKNOWN